Maryland Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9K Buy
+151
New +$17.4K 0.01% 185
2025
Q4
$20.4K Hold
150
0.01% 180
2025
Q3
$22.1K Hold
150
0.01% 172
2025
Q2
$19.4K Hold
150
0.01% 168
2025
Q1
$17.9K Hold
150
0.01% 160
2024
Q4
$17.4K Hold
150
0.01% 164
2024
Q3
$20.3K Hold
150
0.01% 165
2024
Q2
$20.3K Hold
150
0.01% 160
2024
Q1
$19.4K Hold
150
0.01% 151
2023
Q4
$17.2K Hold
150
0.01% 149
2023
Q3
$13.7K Hold
150
0.01% 156
2023
Q2
$16.9K Hold
150
0.01% 152
2023
Q1
$15.7K Hold
150
0.01% 151
2022
Q4
$16.6K Hold
150
0.02% 156
2022
Q3
$13K Hold
150
0.01% 153
2022
Q2
$12K Buy
+150
New +$12.4K 0.01% 159

Other funds holding XYL

Maryland Capital Advisors's XYL Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Xylem (XYL) in Q2 2026: 151 shares worth $17.9K. The stake represents 0.01% of the portfolio and ranks #185 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in XYL as recently as Q4 2025.

Maryland Capital Advisors first reported a position in XYL in Q2 2022 and has held it in 16 quarters since. The position peaked at $22.1K in Q3 2025. 606 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Maryland Capital Advisors held 151 shares of Xylem worth $17.9K as of Q2 2026.
  • Xylem was a new Maryland Capital Advisors position in Q2 2026.
  • Xylem made up 0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #185 holding.
  • Maryland Capital Advisors first reported a position in Xylem in Q2 2022 and has held it in 16 quarters since.
  • Maryland Capital Advisors's Xylem position peaked at $22.1K in Q3 2025.
  • 606 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.